James Li

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study

John F. Greden, Sagar V. Parikh, Anthony J. Rothschild et al. · Journal of Psychiatric Research · 2019 · 340 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimens

David P. Nicolau, Leonard Siew, J. Armstrong et al. · Journal of Antimicrobial Chemotherapy · 2015 · 129 citations · Full text

Medicine, Clinical Pharmacokinetics, Pharmacology +14

Economic Utility: Combinatorial Pharmacogenomics and Medication Cost Savings for Mental Health Care in a Primary Care Setting

Lisa Brown, Raymond A. Lorenz, James Li et al. · Clinical Therapeutics · 2017 · 69 citations · Full text

Medicine, Pharmacoeconomics, Psychiatry +17

Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients

Craig M. McDonald, Francesco Muntoni, Vinay Penematsa et al. · Journal of Comparative Effectiveness Research · 2021 · 62 citations · Full text

Medicine, Internal Medicine, Neurology +14

Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial

Arun K. Tiwari, Clement C. Zai, C. Anthony Altar et al. · Translational Psychiatry · 2022 · 60 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +17